| Patent Number |
Title Of Patent |
Date Issued |
| 5516629 |
Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins |
May 14, 1996 |
| A method for photoinactivating viral and/or bacterial contaminants in blood, blood products or cell cultures is presented. The blood, blood product or cell culture is mixed with an halogenated coumarin sensitizer and irradiated with UV light to inactivate the viral and/or bacterial c |
| 5425951 |
Method of reconstituting lyophilized cells |
June 20, 1995 |
| A process and medium are disclosed for the lyophilization of cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to permit the reconstitution of viable cells. |
| 5418130 |
Method of inactivation of viral and bacterial blood contaminants |
May 23, 1995 |
| A method is provided for inactivating viral and/or bacterial contamination in blood cellular matter, such as erythrocytes and platelets, or protein fractions. The cells or protein fractions are mixed with chemical sensitizers and irradiated with, for example, UV, visible, gamma or X-ray |
| 5342752 |
Method of inactivation of viral blood contaminants using acridine deriatives |
August 30, 1994 |
| A method is provided for inactivating viral and/or bacterial and/or parasitic contamination in cellular blood matter or blood plasma protein fractions, using radiation sensitizing chemical compounds and irradiation with, for example, UV radiation. |
| 5257983 |
Blood bag for lyophilization |
November 2, 1993 |
| A lyophilization bag is provided in which a fluid, such as blood, may be introduced, lyophilized without collapsing the bag, stored, reconstituted and distributed from the bag without intermediate transfer of the useful contents from the bag. |
| 5213814 |
Lyophilized and reconstituted blood platelet compositions |
May 25, 1993 |
| A process and medium are disclosed for the lyophilization of cells, specifically platelets, and cell-like matter, which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible amphipathic polymers to permit the reconstitution of transfusably useful |
| 5178884 |
Lyophilized and reconstituted red blood cell compositions |
January 12, 1993 |
| A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible amphipathic polymers to permit the reconstitution of viable red blood cells. Also disclosed are lyophilized |
| 5171661 |
Medium for lyophilization of erythrocytes |
December 15, 1992 |
| A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible polymers to permit the reconstitution of viable red blood cells. |
| 5153004 |
Freezing and thawing of erythrocytes |
October 6, 1992 |
| A process and medium are disclosed for the freezing of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to permit the thawing without washing to produce viable red blood cells. |
| 5045446 |
Lyophilization of cells |
September 3, 1991 |
| A process and medium are disclosed for the lyophilization of cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to permit the reconstitution of viable cells. |
| 5043261 |
Lyophilized and reconstituted red blood cell and hemosome compositions |
August 27, 1991 |
| A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and biocompatible polymers to permit the reconstitution of viable red blood cells. |
| 4874690 |
Lyophilization of red blood cells |
October 17, 1989 |
| A process and medium are disclosed for the lyophilization of red blood cells which comprises the use of solutions including monosaccharide hexoses and pentoses, biocompatible polymers and polyanions to permit the reconstitution of viable red blood cells. |
